Cargando…
Risk factors for discontinuing oral immunotherapy in children with persistent cow milk allergy
BACKGROUND: There are no universally accepted criteria for discontinuing milk oral immunotherapy (MOIT) in patients with persistent cow milk allergy (CMA) and little data are available on predictive risk factors for dropping out from oral immunotherapy (OIT), due to allergic reactions or other reaso...
Autores principales: | Benelli, Elisa, Trombetta, Andrea, Badina, Laura, Andrade, Stefanny, Zamagni, Giulia, Prisco, Antonio, Traini, Eugenio, Barbi, Egidio, Berti, Irene |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9208286/ https://www.ncbi.nlm.nih.gov/pubmed/35759227 http://dx.doi.org/10.1002/iid3.668 |
Ejemplares similares
-
Life‐threatening anaphylaxis in children with cow's milk allergy during oral immunotherapy and after treatment failure
por: Badina, Laura, et al.
Publicado: (2022) -
Omalizumab effectiveness in patients with a previously failed oral immunotherapy for severe milk allergy
por: Badina, Laura, et al.
Publicado: (2021) -
Early introduction oral immunotherapy for IgE‐mediated cow's milk allergy: A follow‐up study confirms this approach as safe and appealing to parents
por: Badina, Laura, et al.
Publicado: (2021) -
Immunotherapy for cow's milk allergy
por: Taniuchi, Shoichiro, et al.
Publicado: (2017) -
Oral Immunotherapy for Children with Cow’s Milk Allergy
por: Ogata, Mika, et al.
Publicado: (2021)